Augustine Fernandes

744 total citations
19 papers, 526 citations indexed

About

Augustine Fernandes is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Augustine Fernandes has authored 19 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Augustine Fernandes's work include Hemoglobinopathies and Related Disorders (3 papers), Glycosylation and Glycoproteins Research (2 papers) and CAR-T cell therapy research (2 papers). Augustine Fernandes is often cited by papers focused on Hemoglobinopathies and Related Disorders (3 papers), Glycosylation and Glycoproteins Research (2 papers) and CAR-T cell therapy research (2 papers). Augustine Fernandes collaborates with scholars based in United States, India and Spain. Augustine Fernandes's co-authors include Barney A. Schlinger, Yong‐Hwan Kim, Melanie J. Tuerk, Arthur P. Arnold, Colin J. Saldanha, Elizabeta Nemeth, Gloria C. Preza, Tomas Ganz, Ivana De Domenico and Jerry Kaplan and has published in prestigious journals such as Blood, The Journal of Comparative Neurology and Carcinogenesis.

In The Last Decade

Augustine Fernandes

19 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Augustine Fernandes United States 9 144 132 128 119 110 19 526
Wonseok Son South Korea 8 208 1.4× 96 0.7× 15 0.1× 6 0.1× 58 0.5× 15 666
Mikhail Nefedov United States 11 517 3.6× 9 0.1× 32 0.3× 9 0.1× 13 0.1× 14 732
Hua Yan United States 18 492 3.4× 309 2.3× 32 0.3× 3 0.0× 7 0.1× 39 1.1k
Brian T. Nasipak United States 10 256 1.8× 36 0.3× 4 0.0× 28 0.2× 12 0.1× 10 400
Véronique Monnier France 15 567 3.9× 21 0.2× 12 0.1× 19 0.2× 9 0.1× 24 894
Dirk Petersohn Germany 11 255 1.8× 24 0.2× 4 0.0× 26 0.2× 18 0.2× 16 621
Xinwen Zhang China 12 272 1.9× 51 0.4× 5 0.0× 43 0.4× 5 0.0× 41 494
Zhirui Hu United States 9 262 1.8× 43 0.3× 13 0.1× 8 0.1× 5 0.0× 14 428
Brian H. Lee United States 16 811 5.6× 12 0.1× 9 0.1× 11 0.1× 9 0.1× 22 1.2k
Paulo Flávio Silveira Brazil 15 181 1.3× 71 0.5× 5 0.0× 3 0.0× 17 0.2× 56 600

Countries citing papers authored by Augustine Fernandes

Since Specialization
Citations

This map shows the geographic impact of Augustine Fernandes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Augustine Fernandes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Augustine Fernandes more than expected).

Fields of papers citing papers by Augustine Fernandes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Augustine Fernandes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Augustine Fernandes. The network helps show where Augustine Fernandes may publish in the future.

Co-authorship network of co-authors of Augustine Fernandes

This figure shows the co-authorship network connecting the top 25 collaborators of Augustine Fernandes. A scholar is included among the top collaborators of Augustine Fernandes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Augustine Fernandes. Augustine Fernandes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Kao, Pei‐Chi, Emma Morris, Amy Federico, et al.. (2023). Patient and Parent-Reported Outcomes Post-Treatment with Shmir-Based Lentiviral Gene Therapy for Sickle Cell Disease. Blood. 142(Supplement 1). 3750–3750. 1 indexed citations
3.
Kohn, Donald B., Claire Booth, Julián Sevilla, et al.. (2021). A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results. Blood. 138(Supplement 1). 2932–2932. 4 indexed citations
4.
Kohn, Donald B., Elena Almarza, Dayna Terrazas, et al.. (2020). A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Results from Phase 1. Blood. 136(Supplement 1). 15–15. 10 indexed citations
5.
Fernandes, Augustine, Gloria C. Preza, Yen Phung, et al.. (2009). The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood. 114(2). 437–443. 127 indexed citations
6.
Preza, Gloria C., Augustine Fernandes, Richard J. Clark, et al.. (2008). Structural Aspects of Hepcidin-Ferroportin Binding. Blood. 112(11). 119–119. 4 indexed citations
7.
Feng, Ji‐Ming, et al.. (2004). The golli-myelin basic protein negatively regulates signal transduction in T lymphocytes. Journal of Neuroimmunology. 152(1-2). 57–66. 41 indexed citations
8.
Fernandes, Augustine, Celia W. Campagnoni, Kathy Kampf, et al.. (2003). Identification of a protein that interacts with the golli‐myelin basic protein and with nuclear LIM interactor in the nervous system. Journal of Neuroscience Research. 75(4). 461–471. 22 indexed citations
9.
Feng, Ji‐Ming, Augustine Fernandes, Ernesto R. Bongarzone, et al.. (2003). Expression of soma-restricted proteolipid/DM20 proteins in lymphoid cells. Journal of Neuroimmunology. 144(1-2). 9–15. 5 indexed citations
10.
Feng, Ji‐Ming, Augustine Fernandes, & Anthony T. Campagnoni. (2002). Golli–myelin basic proteins delineate the nerve distribution of lymphoid organs. Journal of Neuroimmunology. 123(1-2). 1–8. 7 indexed citations
11.
Murugesan, S., et al.. (2001). 99mTc-labeled field bean protease inhibitor can function as an efficient tumor detecting agent.. PubMed. 39(8). 742–7. 3 indexed citations
12.
Saldanha, Colin J., Melanie J. Tuerk, Yong‐Hwan Kim, et al.. (2000). Distribution and regulation of telencephalic aromatase expression in the zebra finch revealed with a specific antibody. The Journal of Comparative Neurology. 423(4). 619–630. 212 indexed citations
13.
Fernandes, Augustine, et al.. (1998). The field bean protease inhibitor has the potential to suppress B16F10 melanoma cell lung metastasis in mice. Cancer Letters. 129(1). 15–20. 18 indexed citations
15.
Fernandes, Augustine, et al.. (1997). Long-term feeding of field bean protein containing protease inhibitors suppresses virus-induced mammary tumors in mice. Cancer Letters. 116(1). 1–7. 7 indexed citations
16.
Fernandes, Augustine, et al.. (1996). Field bean protease inhibitor mitigates the sister-chromatid exchanges induced by bromoform and depresses the spontaneous sister-chromatid exchange frequency of human lymphocytes in vitro. Mutation Research/Environmental Mutagenesis and Related Subjects. 360(1). 29–35. 2 indexed citations
17.
Fernandes, Augustine, et al.. (1996). The field bean protease inhibitor can effectively suppress 7,12-dimethylbenz[a]anthracene-induced skin tumorigenesis in mice. Cancer Letters. 104(2). 219–224. 10 indexed citations
18.
Fernandes, Augustine, et al.. (1995). Inhibition of benzopyrene-induced forestomach tumors by field bean protease inhibitor(s). Carcinogenesis. 16(8). 1843–1846. 33 indexed citations
19.
Fernandes, Augustine, et al.. (1994). Field bean protease inhibitor preparations, unlike methotrexate, can completely suppress Yoshida sarcoma tumor in rats. Cell Biology International. 18(11). 1025–1034. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026